Track Systemic Inflammatory Regulation & Resolution During TB-500 Protocols
TB-500 is a synthetic analog of Thymosin Beta-4 — a peptide investigated for tissue repair, cell migration, and wound healing. The Inflammation Compass™ evaluates how your protocol translates systemically — measuring whole-blood gene expression to track inflammatory program regulation and active resolution capacity in circulating leukocytes.
Understanding TB-500
Thymosin Beta-4 (Tβ4) is a 43-amino-acid peptide naturally produced in the thymus and found in nearly every cell and body fluid. TB-500 is its synthetic analog — a fragment designed to replicate the tissue-repair and cell-migration properties of the parent peptide.
What Makes TB-500 Unique
TB-500's primary mechanism centers on actin polymerization — the process of building the cell's internal scaffolding. By sequestering G-actin monomers, it promotes cytoskeletal remodeling that enables cells to migrate into damaged tissue, making it fundamentally different from peptides that target metabolic or hormonal pathways.
How It Works
TB-500 upregulates actin to drive cell migration and wound healing. Simultaneously, it promotes angiogenesis through VEGF signaling, modulates inflammation by shifting the IL-10/TNF-α balance, regulates matrix metalloproteinases (MMPs) for tissue remodeling, and has been studied for cardiac repair through GATA-4 and Nkx2.5 transcription factor activation.
Common Therapeutic Uses
In research and clinical settings, TB-500 is explored for wound healing, tendon and ligament repair, joint and muscle recovery, hair regrowth, cardiac tissue repair, and anti-inflammatory applications. It has been studied in both animal models and human-use contexts for its regenerative potential.
Multi-System Preclinical Profile
In preclinical research, TB-500 interfaces with multiple biological systems — cytoskeletal remodeling, endothelial recruitment, cytokine regulation, and progenitor cell mobilization. While local tissue repair must be evaluated at the injury site, whole-blood transcriptomics evaluates how TB-500 protocols shape systemic physiology — specifically evaluating inflammatory program regulation, active resolution, and cellular deconvolution.
Important Note
TB-500 is a research peptide. It is not FDA-approved for any therapeutic use. Biomeme Labs does not endorse, prescribe, or advocate the use of TB-500. The information on this page is provided for educational purposes to explain the biological pathways that transcriptomic monitoring can assess.
Preclinical Mechanisms in the Literature
Published literature examines TB-500 for its cellular migration and cytoskeletal remodeling mechanisms. While localized remodeling occurs at the tissue site, the Inflammation Compass™ evaluates overall systemic inflammatory regulation and active resolution capacity in whole blood across the 3 Health Domains.
Cytoskeletal Remodeling
Preclinical Model: G-Actin Sequestration
Biological role: Actin polymerization is the process of assembling
the cell's internal scaffolding. In preclinical models, TB-500 sequesters G-actin monomers,
promoting lamellipodia formation that enables cell motility toward injury sites.
Systemic connection: While local structural cell migration occurs at the wound site, circulating leukocytes reflect the systemic transition toward homeostatic calming and resolution readiness.
Microvascular Recruitment
VEGF Signaling · Endothelial Support
Biological role: Angiogenesis is the formation of new blood vessels from existing vasculature. In animal models, TB-500 promotes vascular endothelial growth factor (VEGF) signaling to support microvascular supply.
Systemic connection: In whole blood, circulating leukocyte vascular signaling reflects systemic support for microvascular recruitment and endothelial repair without requiring invasive tissue biopsies.
Inflammatory Program Regulation
IL-10 Modulation · Cytokine Balance
Biological role: TB-500 modulates inflammation by shifting cytokine balance — upregulating anti-inflammatory IL-10 while downregulating pro-inflammatory TNF-α and IL-1β in preclinical studies.
Systemic connection: The Inflammation Compass™ directly quantifies cytokine balance and myeloid calming across the Activation and Resolution domains in circulating leukocytes.
Extracellular Matrix Homeostasis
MMP Regulation · Controlled Turnover
Biological role: Matrix metalloproteinases (MMPs) break down and remodel extracellular scaffolding. In preclinical research, TB-500 regulates MMP activity to promote organized matrix turnover rather than excessive degradation.
Systemic connection: In whole blood, circulating leukocyte protease regulation reflects systemic control of matrix turnover and inflammatory resolution.
Regenerative & Progenitor Signaling
Preclinical Model: GATA-4 · Nkx2.5 · Progenitor Dynamics
Biological role: Animal studies have investigated TB-500's activation of cardiac transcription factors (GATA-4, Nkx2.5) and progenitor mobilization during tissue injury repair.
Systemic connection: While cardiac tissue cannot be sampled via routine blood tests, leukocyte transcriptomics tracks systemic cellular recovery and immune readiness across the 3 Health Domains.
Diagnostic Boundary: The Inflammation Compass™ is a whole-blood RNA sequencing test performed by Biomeme Labs. It measures systemic inflammatory program regulation and resolution capacity across the 3 Health Domains (Activation, Antiviral Response, Resolution) plus cellular deconvolution. It does not measure localized tissue actin remodeling, local wound histology, or cardiac-specific transcription factors directly.
Why Standard Labs Fall Short
Standard blood work was never designed to detect tissue repair at the molecular level. It can tell you if something is wrong — but not whether your body is actively rebuilding.
What standard labs tell you
- Standard hs-CRP is a delayed hepatic marker — misses early leukocyte transcriptional shifts
- CBC and CMP show general organ function, not active inflammatory gene programs
- Completely blind to active biological resolution and stand-down machinery
- Cannot distinguish true gene expression regulation from shifts in circulating immune cell counts
What the Inflammation Compass™ reveals
- Quantitative regulation of systemic inflammatory programs (Activation domain)
- Engagement of active resolution and apoptotic clearance machinery (Resolution domain)
- Balanced Type I interferon defense monitoring (Antiviral Response domain)
- Cytokine signaling modulation and oxidative homeostasis in circulating leukocytes
- Cellular deconvolution mapping shifts in myeloid and lymphoid immune subsets
Standard labs remain valuable for overall health monitoring. Transcriptomic analysis adds a molecular layer that traditional tests cannot access.
Track Your TB-500 Response
The Inflammation Compass™ is designed to evaluate how peptide protocols interface with systemic biology — showing whether inflammatory programs are calming, active resolution machinery is engaging, and how your molecular profile changes over time.
Dashboard Coming Soon
We're building a dashboard experience that lets you visualize how TB-500 protocols interface with systemic physiology — inflammatory program regulation, resolution capacity, oxidative homeostasis, and cellular deconvolution — all in one place. Track changes across time points to see how your systemic biological response evolves.
Activation
Inflammatory regulation
Resolution
Stand-down & clearance
Immune Census
Cellular deconvolution
The Inflammation Compass™ evaluates systemic inflammatory program regulation and resolution capacity in circulating leukocytes for TB-500 users today.
Evaluate Inflammatory Regulation & Resolution
With the Inflammation Compass™
Quantify systemic inflammatory calming, cellular stand-down programs, and resolution capacity across the 3 Health Domains. Baseline package ($600) covers 2 complete tests with at-home mobile phlebotomy included.